Related Experiment Video
Updated: Oct 12, 2025

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
Mutational signatures in GATA3 transcription factor and its DNA binding domain that stimulate breast cancer and HDR
Atlal El-Assaad1,2, Zaher Dawy3, Athar Khalil4
1Department of Electrical and Computer Engineering, American University of Beirut (AUB), Riad El Solh, Beirut, Lebanon. atlal.assaad@liu.edu.lb.
Abstract:
Transcription factors (TFs) play important roles in many biochemical processes. Many human genetic disorders have been associated with mutations in the genes encoding these transcription factors, and so those mutations became targets for medications and drug design. In parallel, since many transcription factors act either as tumor suppressors or oncogenes, their mutations are mostly associated with cancer. In this perspective, we studied the GATA3 transcription factor when bound to DNA in a crystal structure and assessed the effect of different mutations encountered in patients with different diseases and phenotypes. We generated all missense mutants of GATA3 protein and DNA within the adjacent and the opposite GATA3:DNA complex models. We mutated every amino acid and studied the new binding of the complex after each mutation. Similarly, we did for every DNA base. We applied Poisson-Boltzmann electrostatic calculations feeding into free energy calculations. After analyzing our data, we identified amino acids and DNA bases keys for binding. Furthermore, we validated those findings against experimental genetic data. Our results are the first to propose in silico modeling for GATA:DNA bound complexes that could be used to score effects of missense mutations in other classes of transcription factors involved in common and genetic diseases.
Insights
This study models transcription factor GATA3 bound to DNA, identifying key amino acids and DNA bases critical for binding. These findings aid in understanding mutations in genetic disorders and cancer, guiding drug design.
Area of Science:
- Biochemistry and Molecular Biology
- Genetics and Genomics
- Structural Biology
Background:
- Transcription factors (TFs) are crucial in biological processes, and mutations in TF genes are linked to human genetic disorders and cancer.
- GATA3 is a TF implicated in various diseases, making its structure and mutation effects important research areas.
Purpose of the Study:
- To investigate the structural and energetic effects of missense mutations in the GATA3 transcription factor and its DNA binding site.
- To develop an in silico model for predicting the impact of mutations on TF:DNA complex stability.
Main Methods:
- Generated all possible missense mutants for GATA3 protein and adjacent/opposite DNA bases in complex models.
- Employed Poisson-Boltzmann electrostatic calculations and free energy calculations to assess binding changes.
- Validated computational findings against existing experimental genetic data.
Main Results:
- Identified specific amino acids and DNA bases that are key determinants of GATA3:DNA binding.
- Demonstrated the utility of in silico modeling in predicting mutation effects on TF:DNA interactions.
- Corroborated computational predictions with experimental genetic data.
Conclusions:
- The developed in silico model provides a novel approach for scoring missense mutations in TF:DNA complexes.
- This methodology can be applied to other transcription factors involved in genetic diseases and cancer, aiding therapeutic strategies.
More Related Videos
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
09:01Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
Published on: July 3, 2025
Related Concept Videos
TGF - β Signaling Pathway
The Ras Gene
Ras is a...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
lncRNA - Long Non-coding RNAs